John Chin
Advanced Heart Failure and Transplant Cardiology · Sacramento, CANPI 1134291206
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $141,755 of the $182,153 with a category attached, or 77.8%. 19 manufacturers reported payments, led by Johnson & Johnson at 57.4% of the total. Reporting peaked in 2019 at $96,700 and has fallen 100.0% since, to $16 in 2025.
Across 236 payments — averaging $771.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$105K
- Novartis$33K
- AstraZeneca$28K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$4K
- Akcea Therapeutics, Inc.$3K
- Vifor Pharma, Inc.$3K
- plus $7K from 13 others
Across 12 payments — averaging $1915.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$23K
- Amgen$5
What the payments were for
- Consulting fees$19,33011%
- Speaking & faculty fees$141,75578%
- Travel & lodging$13,2737%
- Food & beverage$7,7774%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 92 | $104,547 |
| Novartis | 28 | $33,305 |
| AstraZeneca | 38 | $28,064 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $4,128 |
| Akcea Therapeutics, Inc. | 5 | $2,708 |
| Vifor Pharma, Inc. | 9 | $2,653 |
| Amgen | 2 | $2,406 |
| Abbott | 19 | $1,664 |
| Biotronik Inc. | 6 | $897 |
| Pfizer | 2 | $719 |
| Abiomed | 2 | $248 |
| Medtronic | 3 | $220 |
| Actelion Pharmaceuticals US, Inc. | 3 | $190 |
| Portola Pharmaceuticals, LLC | 1 | $127 |
| Boston Scientific | 3 | $122 |
| Acist Medical Systems, Inc. | 1 | $78 |
| Heartflow, Inc. | 1 | $55 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$103,286
- ENTRESTO$32,949
- LOKELMA$15,001
- FARXIGA$12,626
- LifeVest$3,302
- Veltassa$2,598
- Corlanor$2,380
- VYNDAQEL$700
- HeartMate 3 Left Ventricular Assist Device$577
- CardioMEMS HF System$310
- HeartMate 3 Left Ventricular Dev$297
- Impella$248
- HeartWare HVAD$138
- ANDEXXA$127
- OPSUMIT$123
How this compares
$182,153 in reported general payments places this provider in the 85th percentile of 111 advanced heart failure and transplant cardiology providers in California.
See all advanced heart failure and transplant cardiology providers in California →
Other advanced heart failure and transplant cardiology in Sacramento
- Munir JanmohamedSacramento$314K
- Gurpreet SodhiSacramento$241K
- Nancy LuoSacramento$118K
- Zi Jian XuSacramento$67K
- Imo EbongSacramento$65K
- Richard WrightSanta Monica$1.7M
- James Heywoodla Jolla$1.2M
- Hirsch MehtaSan Diego$494K
- Teresa de MarcoSan Francisco$366K
- Rajeev Mohanla Jolla$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.